These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19758789)

  • 1. HTR2A gene variation is involved in antidepressant treatment response.
    Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
    Noro M; Antonijevic I; Forray C; Kasper S; Kocabas NA; Lecrubier Y; Linotte S; Mendlewicz J; Montgomery S; Snyder L; Souery D; Verbanck P; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):228-31. PubMed ID: 20453658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
    McMahon FJ; Buervenich S; Charney D; Lipsky R; Rush AJ; Wilson AF; Sorant AJM; Papanicolaou GJ; Laje G; Fava M; Trivedi MH; Wisniewski SR; Manji H
    Am J Hum Genet; 2006 May; 78(5):804-814. PubMed ID: 16642436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.
    Horstmann S; Lucae S; Menke A; Hennings JM; Ising M; Roeske D; Müller-Myhsok B; Holsboer F; Binder EB
    Neuropsychopharmacology; 2010 Feb; 35(3):727-40. PubMed ID: 19924111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
    Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
    Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of 34 candidate genes in bupropion and placebo remission.
    Tiwari AK; Zai CC; Sajeev G; Arenovich T; Müller DJ; Kennedy JL
    Int J Neuropsychopharmacol; 2013 May; 16(4):771-81. PubMed ID: 22947179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further Support for the Involvement of Genetic Variants Related to the Serotonergic Pathway in the Antidepressant Response in Children and Adolescents After a 12-Month Follow-Up: Impact of the
    Gassó P; Blázquez A; Rodríguez N; Boloc D; Torres T; Mas S; Lafuente A; Lázaro L
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):711-718. PubMed ID: 29975559
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatization in major depression--clinical features and genetic associations.
    Klengel T; Heck A; Pfister H; Brückl T; Hennings JM; Menke A; Czamara D; Müller-Myhsok B; Ising M
    Acta Psychiatr Scand; 2011 Oct; 124(4):317-28. PubMed ID: 21838737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population.
    Kishi T; Kitajima T; Tsunoka T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Inada T; Ozaki N; Iwata N
    Neurosci Res; 2009 Jun; 64(2):231-4. PubMed ID: 19428704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment--a European multicentre study.
    Höfer P; Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Konstantinidis A; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
    Int Clin Psychopharmacol; 2016 Jan; 31(1):1-7. PubMed ID: 26544898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
    Kishi T; Yoshimura R; Kitajima T; Okochi T; Okumura T; Tsunoka T; Yamanouchi Y; Kinoshita Y; Kawashima K; Naitoh H; Nakamura J; Ozaki N; Iwata N
    Neuromolecular Med; 2010 Sep; 12(3):237-42. PubMed ID: 19937159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic studies of drug response and side effects in the STAR*D study, part 2.
    Garriock HA; Hamilton SP
    J Clin Psychiatry; 2009 Sep; 70(9):1323-5. PubMed ID: 19818256
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of catechol-O-methyltransferase variants with duloxetine response in major depressive disorder.
    Houston JP; Kohler J; Ostbye KM; Heinloth A; Perlis RH
    Psychiatry Res; 2011 Oct; 189(3):475-7. PubMed ID: 21788083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis.
    Lin JY; Jiang MY; Kan ZM; Chu Y
    J Affect Disord; 2014 Oct; 168():430-8. PubMed ID: 25108775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
    Laje G; Cannon DM; Allen AS; Klaver JM; Peck SA; Liu X; Manji HK; Drevets WC; McMahon FJ
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):715-24. PubMed ID: 20047709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genomewide association study of citalopram response in major depressive disorder.
    Garriock HA; Kraft JB; Shyn SI; Peters EJ; Yokoyama JS; Jenkins GD; Reinalda MS; Slager SL; McGrath PJ; Hamilton SP
    Biol Psychiatry; 2010 Jan; 67(2):133-8. PubMed ID: 19846067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.